Article Details

AstraZeneca buying hypertension-focused CinCor for up to $1.8 billion - Axios

Retrieved on: 2023-01-09 17:27:42

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca buying hypertension-focused CinCor for up to $1.8 billion - Axios. View article details on HISWAI: https://www.axios.com/astrazeneca-buying-hypertension-focused-cincor-for-up-to-18-billion-4c61ee8d-a12b-4512-a8f5-6d0e35bb8e96.html

Excerpt

CinCor went public in early 2022, and major shareholders still include Sofinnova Ventures (13.89%), 5AM Ventures (11.28%), Sofinnova Partners ...

Article found on: www.axios.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up